الرئيسية › ميلانوما › بنسلفانيا › Pittsburgh
التجارب السريرية لـ ميلانوما في Pittsburgh، PA
31 دراسات لـ ميلانوما تبحث عن مشاركين في مواقع داخل وحول Pittsburgh (ضمن نطاق 30 ميلًا تقريبًا). افتح الدراسة لمعرفة من يمكنه المشاركة وكيفية التواصل مع فريق الدراسة.
النص الرسمي للدراسة (بالإنجليزية)
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
جارٍ التسجيلالمرحلة 3
- University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center, Pittsburgh
A Study on How to Safely Guide Surgery for Melanoma and Similar Skin Tumors in Children Using Pathology and Genetic Information
جارٍ التسجيلالمرحلة 2
- Children's Hospital of Pittsburgh of UPMC, Pittsburgh
Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.
جارٍ التسجيلالمرحلة 3
- Allegheny Health Network, Pittsburgh
Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
جارٍ التسجيلالمرحلة 3
- UPMC Hillman Cancer Center, Pittsburgh
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
جارٍ التسجيلالمرحلة 2
- University of Pittsburgh Cancer Institute (UPCI), Pittsburgh
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
جارٍ التسجيلالمرحلة 1/2
- University of Pittsburgh Medical Center, Pittsburgh
Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer
جارٍ التسجيلالمرحلة 1/2
- UPMC Hillman Cancer Center, Pittsburgh
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
جارٍ التسجيلالمرحلة 1/2
- Children's Hospital of Pittsburgh of UPMC, Pittsburgh
Project: Every Child for Younger Patients With Cancer
جارٍ التسجيلدراسة رصدية
- Children's Hospital of Pittsburgh of UPMC, Pittsburgh
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
جارٍ التسجيلالمرحلة 1/2
- Research Site, Pittsburgh
Investigating Real-Time Immunotherapy Symptoms Study
جارٍ التسجيل
- UPMC Hillman Cancer Center, Pittsburgh
Safety and Efficacy of OBX-115 in Advanced Solid Tumors
جارٍ التسجيلالمرحلة 1/2
- Allegheny Research Institute (Melanoma/NSCLC), Pittsburgh
Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies
جارٍ التسجيلالمرحلة 2
- UPMC Hillman Cancer Center, Pittsburgh
A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer
جارٍ التسجيلالمرحلة 1/2
- UPMC Hillman Cancer Center, Pittsburgh
Evolution of Metabolic and Immune Dysfunction in In-transit Melanoma
جارٍ التسجيلدراسة رصدية
- UPMC Hillman Cancer Center, Pittsburgh
MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma
جارٍ التسجيلالمرحلة 1/2
- UPMC Hillman Cancer Center, Pittsburgh
Evaluation of Hypoxia in Primary Melanoma
جارٍ التسجيلدراسة رصدية
- UPMC Hillman Cancer Center, Pittsburgh
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
جارٍ التسجيلالمرحلة 1/2
- University of Pittsburgh Medical Center, Pittsburgh
Neoadjuvant Darovasertib in Primary Uveal Melanoma
جارٍ التسجيلالمرحلة 3
- UPMC Hillman Cancer Center, Pittsburgh
A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body
جارٍ التسجيلالمرحلة 1/2
- University of Pittsburgh Medical Center - Hillman Cancer Center, Pittsburgh
A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
جارٍ التسجيلالمرحلة 1
- UPMC Hillman Cancer Center, Pittsburgh
Patient Preference for Subcutaneous vs. Intravenous Immune Therapy
جارٍ التسجيلالمرحلة 2
- UPMC Hillman Cancer Center, Pittsburgh
RP1 in Primary Melanoma to Reduce the Risk of Sentinel Lymph Node Metastasis
جارٍ التسجيلالمرحلة الأولى المبكرة
- UPMC Hillman Cancer Center, Pittsburgh
A Study of VET3-TGI in Patients With Solid Tumors
جارٍ التسجيلالمرحلة 1
- UPMC- Hillman Cancer Center, Pittsburgh
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
جارٍ التسجيلالمرحلة 2/3
- UPMC Hillman Cancer Center, Pittsburgh
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
جارٍ التسجيلالمرحلة 3
- UPMC Hillman Cancer Center, Pittsburgh
Effects of Anti-PD1 Adjuvant Checkpoint Blockade Immunotherapy on Atypical/Dysplastic Nevi
جارٍ التسجيلدراسة رصدية
- UPMC Hillman Cancer Center, Pittsburgh
Phase 1/2 Study of Intratumoral Injection of STX-001 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab
جارٍ التسجيلالمرحلة 1/2
- University of Pittsburgh Medical Center, Pittsburgh
A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors
جارٍ التسجيلالمرحلة 1/2
- University of Pittsburgh Medical Center, Pittsburgh
A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors
جارٍ التسجيلالمرحلة 1/2
- UPMC Hillman Cancer Center, Pittsburgh
Safety, Tolerability, and Preliminary Efficacy of CJRB-101 With Pembrolizumab in Subjects With Selected Types of Advanced or Metastatic Cancer
جارٍ التسجيلالمرحلة 1/2
- University of Pittsburgh, Pittsburgh
تجارب ميلانوما في مدن أخرى
- Houston, TX59 دراسات
- New York City, NY38 دراسات
- Los Angeles, CA34 دراسات
- Nashville, TN32 دراسات
- Boston, MA25 دراسات
- Philadelphia, PA23 دراسات
- San Francisco, CA22 دراسات
- Atlanta, GA21 دراسات
- Columbus, OH21 دراسات
- Salt Lake City, UT21 دراسات
- Durham, NC21 دراسات
- Arlington, VA20 دراسات
دراسات أخرى في Pittsburgh
- سرطان الرئة غير صغير الخلايا48 دراسات
- السرطان (جميع الأنواع)42 دراسات
- سرطان الثدي39 دراسات
- سرطان القولون والمستقيم32 دراسات
- السرطان النقيلي31 دراسات
- سرطان المبيض30 دراسات
- سرطان بطانة الرحم24 دراسات
- سرطان الرئة23 دراسات
- سرطان البروستاتا23 دراسات
- السكتة الدماغية22 دراسات
- سرطان الخلايا الحرشفية في الرأس والرقبة22 دراسات
- الاكتئاب22 دراسات
من ClinicalTrials.gov، البيانات مستخرجة في 01/10/2026. كل دراسة تحدد معايير أهليتها الخاصة؛ فريق الدراسة هو من يحدد من يمكنه المشاركة.